MAJI OTC
Nextel Medical Corp.
1W: -22.4%
1M: -41.5%
3M: -52.5%
YTD: -93.1%
$0.00
-0.00 (-10.00%)
Weekly Expected Move ±35.2%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$500
+0.0% ▲
Gross Profit
-$173K
+0.0% ▲
Operating Income
-$509K
+0.0% ▲
Net Income
$14M
+0.0% ▲
EPS (Diluted)
$0.33
+0.0% ▲
EBITDA
-$483K
+0.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2026 |
|---|---|
| Revenue | $500 |
| YoY Growth | +0.0% |
| Cost of Revenue | $174K |
| Gross Profit | -$173K |
| Gross Margin | -34614.0% |
| R&D Expenses | $253K |
| SG&A Expenses | $83K |
| Operating Expenses | $336K |
| Operating Income | -$509K |
| Operating Margin | -101746.8% |
| Interest Expense | $32K |
| Income Before Tax | $14M |
| Tax Expense | $0 |
| Net Income | $14M |
| Net Margin | 2703644.6% |
| EPS (Diluted) | $0.33 |
| EBITDA | -$483K |
| Shares Outstanding | 41M |